DK1819729T3 - Fremgangsmåde til fremstilling af carboxy-terminalt amiderede peptider - Google Patents
Fremgangsmåde til fremstilling af carboxy-terminalt amiderede peptiderInfo
- Publication number
- DK1819729T3 DK1819729T3 DK05850211T DK05850211T DK1819729T3 DK 1819729 T3 DK1819729 T3 DK 1819729T3 DK 05850211 T DK05850211 T DK 05850211T DK 05850211 T DK05850211 T DK 05850211T DK 1819729 T3 DK1819729 T3 DK 1819729T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboxy
- preparation
- terminally amidated
- amidated peptides
- terminal
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 2
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 abstract 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004058306A DE102004058306A1 (de) | 2004-12-01 | 2004-12-01 | Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden |
| PCT/EP2005/012365 WO2006058620A2 (de) | 2004-12-01 | 2005-11-18 | Verfahren zur herstellung von carboxy-terminal amidierten peptiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1819729T3 true DK1819729T3 (da) | 2009-08-17 |
Family
ID=36001270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05850211T DK1819729T3 (da) | 2004-12-01 | 2005-11-18 | Fremgangsmåde til fremstilling af carboxy-terminalt amiderede peptider |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7939293B2 (da) |
| EP (1) | EP1819729B8 (da) |
| JP (1) | JP4857279B2 (da) |
| KR (1) | KR101299417B1 (da) |
| CN (1) | CN101068833B (da) |
| AT (1) | ATE429445T1 (da) |
| AU (1) | AU2005312165B2 (da) |
| BR (1) | BRPI0518759A2 (da) |
| CA (1) | CA2589951C (da) |
| CY (1) | CY1110488T1 (da) |
| DE (2) | DE102004058306A1 (da) |
| DK (1) | DK1819729T3 (da) |
| ES (1) | ES2324951T3 (da) |
| HK (1) | HK1111426A1 (da) |
| IL (1) | IL183467A0 (da) |
| MX (1) | MX2007005840A (da) |
| PL (1) | PL1819729T3 (da) |
| PT (1) | PT1819729E (da) |
| SI (1) | SI1819729T1 (da) |
| WO (1) | WO2006058620A2 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005046113A1 (de) * | 2005-09-27 | 2007-03-29 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen |
| DE102006031955A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
| DE102006031962A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
| DE102007002580A1 (de) * | 2007-01-11 | 2008-07-17 | C-Lecta Gmbh | Proteolytische Abspaltung von Protein-Tags in der rekombinanten Protein-Herstellung |
| DE102008025007A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| JP5694779B2 (ja) | 2008-01-09 | 2015-04-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体 |
| DE102008003566A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| DE102008003568A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| KR20100111683A (ko) | 2008-01-09 | 2010-10-15 | 사노피-아벤티스 도이칠란트 게엠베하 | 극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체 |
| DE102008025008A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| PT2498801T (pt) | 2009-11-13 | 2018-05-02 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina |
| US10029011B2 (en) | 2009-11-13 | 2018-07-24 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine |
| JP5198427B2 (ja) * | 2009-12-29 | 2013-05-15 | ザインエレクトロニクス株式会社 | シグマデルタ変調器 |
| SG187904A1 (en) | 2010-08-30 | 2013-04-30 | Sanofi Aventis Deutschland | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| KR101983982B1 (ko) | 2011-08-29 | 2019-05-30 | 사노피-아벤티스 도이칠란트 게엠베하 | 2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물 |
| AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
| TWI641381B (zh) | 2013-02-04 | 2018-11-21 | 法商賽諾菲公司 | 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物 |
| MX2016008979A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina. |
| EP3091965A1 (en) | 2014-01-09 | 2016-11-16 | Sanofi | Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| US9895423B2 (en) | 2014-01-09 | 2018-02-20 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
| NZ733670A (en) | 2014-12-12 | 2021-12-24 | Sanofi Aventis Deutschland | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708934A (en) | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
| US5496924A (en) | 1985-11-27 | 1996-03-05 | Hoechst Aktiengesellschaft | Fusion protein comprising an interleukin-2 fragment ballast portion |
| JP2598050B2 (ja) | 1987-07-17 | 1997-04-09 | サントリー株式会社 | Ｃ−末端α−アミド化酵素 |
| US5789234A (en) | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| US6255067B1 (en) | 1987-09-15 | 2001-07-03 | The Johns Hopkins University | cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM) |
| US6319695B1 (en) | 1991-10-15 | 2001-11-20 | The Scripps Research Insitute | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose |
| US5338833A (en) * | 1992-07-23 | 1994-08-16 | The University Of North Carolina At Chapel Hill | Carboxy terminal IL-6 muteins |
| US5589364A (en) * | 1994-07-29 | 1996-12-31 | Magainin Pharmaceuticals Inc. | Recombinant production of biologically active peptides and proteins |
| JP3291172B2 (ja) | 1994-10-04 | 2002-06-10 | キヤノン株式会社 | 金属製ミラーの製造方法 |
| WO1996017941A2 (en) * | 1994-12-07 | 1996-06-13 | Bionebraska, Inc. | Production of c-terminal amidated peptides from recombinant protein constructs |
| US6723530B1 (en) * | 1997-02-05 | 2004-04-20 | Amylin Pharmaceuticals, Inc. | Polynucleotides encoding proexendin, and methods and uses thereof |
| US6461834B1 (en) | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
| US6924264B1 (en) * | 1999-04-30 | 2005-08-02 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists |
| EP1076066A1 (en) * | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
| US6528486B1 (en) * | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
| US6992172B1 (en) * | 1999-11-12 | 2006-01-31 | Fibrogen, Inc. | Recombinant gelatins |
| DE10123348A1 (de) * | 2001-05-14 | 2002-11-21 | Fresenius Kabi De Gmbh | DNS-Konstrukte für die Herstellung von Peptiden |
| RU2376314C2 (ru) * | 2002-10-02 | 2009-12-20 | Зилэнд Фарма А/С | Стабилизированные соединения эксендина-4 |
-
2004
- 2004-12-01 DE DE102004058306A patent/DE102004058306A1/de not_active Withdrawn
-
2005
- 2005-11-18 DE DE502005007161T patent/DE502005007161D1/de active Active
- 2005-11-18 PT PT05850211T patent/PT1819729E/pt unknown
- 2005-11-18 WO PCT/EP2005/012365 patent/WO2006058620A2/de active Application Filing
- 2005-11-18 KR KR1020077012501A patent/KR101299417B1/ko not_active IP Right Cessation
- 2005-11-18 SI SI200530733T patent/SI1819729T1/sl unknown
- 2005-11-18 CA CA2589951A patent/CA2589951C/en not_active Expired - Fee Related
- 2005-11-18 CN CN2005800412833A patent/CN101068833B/zh not_active Expired - Fee Related
- 2005-11-18 AU AU2005312165A patent/AU2005312165B2/en not_active Ceased
- 2005-11-18 BR BRPI0518759-1A patent/BRPI0518759A2/pt active Search and Examination
- 2005-11-18 JP JP2007543728A patent/JP4857279B2/ja not_active Expired - Fee Related
- 2005-11-18 EP EP05850211A patent/EP1819729B8/de not_active Not-in-force
- 2005-11-18 MX MX2007005840A patent/MX2007005840A/es active IP Right Grant
- 2005-11-18 AT AT05850211T patent/ATE429445T1/de active
- 2005-11-18 ES ES05850211T patent/ES2324951T3/es active Active
- 2005-11-18 DK DK05850211T patent/DK1819729T3/da active
- 2005-11-18 US US11/720,006 patent/US7939293B2/en active Active
- 2005-11-18 PL PL05850211T patent/PL1819729T3/pl unknown
-
2007
- 2007-05-28 IL IL183467A patent/IL183467A0/en not_active IP Right Cessation
-
2008
- 2008-02-21 HK HK08101877.8A patent/HK1111426A1/xx not_active IP Right Cessation
-
2009
- 2009-06-30 CY CY20091100691T patent/CY1110488T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2324951T3 (es) | 2009-08-20 |
| KR101299417B1 (ko) | 2013-08-28 |
| PT1819729E (pt) | 2009-06-12 |
| AU2005312165A1 (en) | 2006-06-08 |
| SI1819729T1 (sl) | 2009-10-31 |
| DE502005007161D1 (de) | 2009-06-04 |
| EP1819729B1 (de) | 2009-04-22 |
| WO2006058620A2 (de) | 2006-06-08 |
| WO2006058620A3 (de) | 2006-08-03 |
| JP2008521415A (ja) | 2008-06-26 |
| CY1110488T1 (el) | 2015-04-29 |
| BRPI0518759A2 (pt) | 2008-12-09 |
| MX2007005840A (es) | 2007-07-04 |
| EP1819729A2 (de) | 2007-08-22 |
| CA2589951C (en) | 2013-10-15 |
| HK1111426A1 (en) | 2008-08-08 |
| IL183467A0 (en) | 2007-09-20 |
| DE102004058306A1 (de) | 2006-07-27 |
| JP4857279B2 (ja) | 2012-01-18 |
| CA2589951A1 (en) | 2006-06-08 |
| US20090005299A1 (en) | 2009-01-01 |
| CN101068833A (zh) | 2007-11-07 |
| KR20070091131A (ko) | 2007-09-07 |
| AU2005312165B2 (en) | 2011-08-04 |
| PL1819729T3 (pl) | 2009-09-30 |
| CN101068833B (zh) | 2011-04-20 |
| US7939293B2 (en) | 2011-05-10 |
| ATE429445T1 (de) | 2009-05-15 |
| EP1819729B8 (de) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1819729T3 (da) | Fremgangsmåde til fremstilling af carboxy-terminalt amiderede peptider | |
| BR0212203A (pt) | Composições e processos para tratamento de diabetes | |
| HUP0301723A2 (hu) | Eljárás peptidek előállítására in vitro transzkripciós/transzlációs rendszer alkalmazásával | |
| MY148447A (en) | Method for amidating polypeptides with basic aminoacid d-terminals by means of specific endoproteases | |
| WO2007001264A3 (en) | Method of making recombinant human antibodies for use in biosensor technology | |
| MY150549A (en) | Process for concentration of antibodies and therapeutic products thereof | |
| MX2008012748A (es) | Un proceso para la concentracion de un polipeptido. | |
| DE60230040D1 (de) | Fermentationsverfahren zur herstellung von l-aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae | |
| DE602005009856D1 (de) | Verfahren zur reinigung von fsh | |
| MX2009006659A (es) | Anticuerpos y metodos de elaboracion y uso. | |
| DE102005001078A8 (de) | Glaspulver, insbesondere biologisch aktives Glaspulver und Verfahren zur Herstellung von Glaspulver, insbesondere biologisch aktivem Glaspulver | |
| ATE483766T1 (de) | Druckverfahren zur herstellung teilchenförmiger produkte | |
| WO2010063818A3 (en) | Methods for selecting protease resistant polypeptides | |
| DE50010015D1 (de) | Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung | |
| DK2094841T3 (da) | Fremgangsmåde til fremstilling af pravastatin | |
| ATE452141T1 (de) | Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen | |
| DE502006005580D1 (de) | Verfahren zur herstellung von optisch aktiven 3-phenylpropionsäurederivaten und folgeprodukte davon | |
| TW200633757A (en) | Method of supercritical distillation | |
| DE60307614D1 (de) | Polyelektrolytmembran, Verfahren zur Produktion und Brennstoffzelle enthaltend diese Polyelektrolytmembran | |
| MX2012000087A (es) | Metodo cromatografico basado en gradiente no lineal preparativo y productos purificados del mismo. | |
| DE60308176D1 (de) | Vorrichtung von peptid- oder proteindarstellung, verfahren zu deren herstellung und deren verwendung | |
| WO2006084672A3 (en) | Process of extraction by means of purification of staminal cells and/or autologous fibroblasts and their derivatives and cellular product obtained with said process | |
| WO2004103292A3 (en) | Process for manufacture of nematode-extracted anticoagulant protein (nap) | |
| DE50203529D1 (de) | Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte | |
| DE10293636D2 (de) | Verfahren zum Abreichern von Kohlendioxid, Verfahren zur Energiegewinnung, Energie bzw. Strom, Codukt, Verfahren zum Handlen von Kohlenstoff, von Kohlenstoffäquivalenten und Codukten |